Page 51 - Functional impairment and cues for rehabilitation of head and neck cancer patients -
P. 51
Swallowing function after treatment for early-stage OPC
2
49
Appendix 7 Continued
Coughing
No 37 (97) Yes 1 (3) Unknown 28
No 28
68 (86) 11 (14) 47
65 (82) 14 (18) 47
37 (90) 4 (10) 37
31 (71) 14 (30) 34
31 (91) 3 (9) 32
33 (97) 1 (3) 32
58 (87) 9 (13) 59
59 (88) 8 (12) 59
46 (98) 1 (2) 31
36 (77) 11 (23) 31
MA: 1.8 (0.4–7.7) A: 1.8 (0.2–18.1)
Trouble opening mouth
(74) (26)
MA: 0.6 (0.2–1.5) A: 0.6 (0.3–1.6)
.240 .333
MA: 2.1 (0.3–16.7) A: 5.0 (0.6–40.5)
.494 .130
Dry mouth
Yes 10 Unknown 28
No 28
Yes 10 Unknown 28
No 32
Yes 6 (16) Unknown 28
No 32 (84) Yes 6 (16) Unknown 28
18 (23) 61 (77) 47
63 (80) 16 (20) 47
10 (22) 35 (78) 33
38 (84) 7 (16) 33
MA: 3.4 (1.5–7.4) A: 3.3 (1.5–7.1)
.003 .003
27 (79) 7 (21) 32
29 (85) 5 (15) 32
13 (19) 55 (81) 58
60 (91) 6 (9) 60
19 (40) 28 (60) 31
40 (85) 7 (15) 31
MA: 4.7 (1.9–11.8) A: 4.7 (1.9.1–11.6)
.001 .001
Bothersome appearance
(84)
MA: 4.5 (0.7–30.1) A: 4.1 (0.7–22.7)
.117 .107
MA: 0.6 (0.2–2.7) A: 0.5 (0.1–2.0)
.547 .311
Altered taste
33 (42) 46 (58) 47
16 (36) 28 (64) 34
MA: 3.2 (1.3–7.9) A: 2.9 (1.2–7.0)
.014 .020
28 (82) 6 (18) 32
33 (49) 35 (52) 58
30 (64) 17 (36) 31
MA: 2.9 (1.1–7.4) A: 2.6 (1.0–7.1)
.029 .058
Study specific outcomes PEG tube in situ
No 64 (97) Yes 2 (3) Unknown 0
97 (77) 29 (23)
0
126 (100) 0 (0)
57 (77) 17 (23) 4
73 (97) 2 (3)
MA: 4.9 (0.7–36.6) A: 4.2 (0.5–33.7)
.118 .178
64 (99) 1 (2)
1
63 (97) 2 (3)
110 (90) 12 (10)
4
122 (100) 0 (0)
67 (91) 7 (10) 4
73 (99) 1 (1)
NA NA
Tracheostomy in situ No 63 (96) Yes 3 (5)
NA
Unknown 0
NB: Not all percentages sum up exactly to 100% due to rounding.
3
1
4
4
4-month follow-up
12-month follow-up
Number of participants (%)
Regression analysis
Number of participants (%)
Regression analysis
Surgery (n = 66)
RT
(n = 126)
Surgery and received surgery + (C)RT (n = 78)
RR (95% CI) NA
P value
Surgery (n = 66)
RT
(n = 126)
Surgery and received surgery + (C)RT (n = 78)
RR (95% CI)
P value .457
(74) (26)
0
Abbreviations: A = adjusted model (adjusted for age, gender, ACE-27, smoking status, tumour site, TNM-stage, HPV-status and pre-treatment swallowing problems), CI = confidence interval, MA: minimally adjusted model (adjusted for age and gender), PEG = percutaneous endoscopic gastrostomy, RR = risk ratio.
.623